MDT · earnings call history
Medtronic plc Q4 FY26 — Strongest Top Line Growth in a Decade Driven by CAS and Hugo Momentum
Read the briefMedtronic Q3 FY26 — Strong Organic Revenue Growth Driven by PFA and New Product Launches
Read the briefMedtronic plc Q2 FY26 — Growth Acceleration Underway, Guidance Raised
Read the briefMedtronic Q1 FY26 — Strong Growth Accelerators and Raised Outlook
Read the briefMedtronic Q3 FY25 — Strong PFA Growth and Earnings Leverage
Read the briefBrowse all US companies on the earnings-call register.